Taiwanese firm teams up with U.S. to develop coronavirus vaccine
Taipei, Feb. 17 (CNA) Taiwan-based Medigen Vaccine Biologics Corp. (MVC) announced Monday that it has teamed up with the U.S. National Institutes of Health (NIH) to develop a vaccine against COVID-19 coronavirus.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Kaohsiung districts close schools, offices on mudslide fears06/22/2021 11:14 AM
Taiwan headline news06/22/2021 10:11 AM
U.S. dollar down in Taipei trading06/22/2021 10:09 AM
Taiwan shares open higher06/22/2021 09:12 AM
COVID-19 vaccine mixing currently not an option: Taiwan's CECC06/21/2021 10:12 PM